Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 148 Results

Title
Intervention Indication Therapeutic Area Year Actions
Dasiglucagon for treating congenital hyperinsulinism Dasiglucagon (ZP 4207) Congenital hyperinsulinism , Hypoglycaemia Endocrine Nutritional and Metabolic Disorders 2021 View  |  Download
Darolutamide in addition to docetaxel and androgen deprivation therapy for metastatic hormone-sensitive prostate cancer Darolutamide (ODM-201; BAY-1841788; Nubeqa) , Docetaxel (Taxotere; docetaxel trihydrate; docetaxel anhydrous) Prostate cancer Male Reproductive Cancer 2021 View  |  Download
Daprodustat for anaemia associated with chronic kidney disease Daprodustat (GSK1278863) Anaemia Cardiovascular System , Haematology , Nephrology 2021 View  |  Download
CTX001 for transfusion-dependent beta-thalassaemia CTX001 Beta thalassemia Genetic Disorders , Haematology 2021 View  |  Download
CTX001 for severe sickle cell disease CTX001 Leukocyte adhesion deficiency , Sickle cell disease (SCD) Haematology , Immunology 2021 View  |  Download
Crizotinib for paediatric ALK-positive anaplastic large cell lymphoma or inflammatory myofibroblastic tumour Crizotinib (Xalkori; PF-02341066; Xalkor) Anaplastic large cell lymphoma (ALCL) , Myofibroblastic tumour Haematological Cancer and Lymphomas 2021 View  |  Download
Conbercept for neovascular age-related macular degeneration Conbercept (KH902) Age-related macular degeneration (AMD) Ophthalmology 2021 View  |  Download
Clostridium botulinum type A toxin-haemagglutinin complex (Dysport) for urinary incontinence Botulinum toxin A (Dysport; AbobotulinumtoxinA; Xeomin; Incobotulinumtoxin A; ANT-1207; Botox; OnabotulinumtoxinA; RT002; Daxibotulinumtoxin A; Azzalure; RT-001; NT 201; AGN-151607) Neurogenic detrusor overactivity , Urinary incontinence Neurology , Urology 2021 View  |  Download
Ciltacabtagene autoleucel for relapsed and refractory multiple myeloma Ciltacabtagene Autoleucel (JNJ-68284528; LCAR-B38M CAR-T cell therapy; LCAR-B38M; JNJ 4528) Multiple myeloma (MM) Haematological Cancer and Lymphomas , Haematology 2021 View  |  Download
Cemiplimab in combination with chemotherapy for advanced or metastatic non-small cell lung cancer – first-line Cemiplimab (Libtayo; REGN2810) , Ipilimumab (Yervoy; BMS 734016; MDX 101) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2021 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications